Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$4.64 - $5.98 $12,291 - $15,841
-2,649 Reduced 8.93%
27,026 $135,000
Q1 2023

May 12, 2023

SELL
$4.85 - $7.84 $1,576 - $2,548
-325 Reduced 1.08%
29,675 $153,000
Q4 2022

Feb 14, 2023

SELL
$6.09 - $8.25 $39,548 - $53,575
-6,494 Reduced 17.79%
30,000 $183,000
Q1 2022

May 16, 2022

SELL
$8.0 - $10.06 $28,048 - $35,270
-3,506 Reduced 8.77%
36,494 $352,000
Q4 2021

Feb 14, 2022

SELL
$8.0 - $9.74 $80,000 - $97,400
-10,000 Reduced 20.0%
40,000 $320,000
Q2 2021

Aug 16, 2021

SELL
$8.5 - $10.95 $42,500 - $54,750
-5,000 Reduced 9.09%
50,000 $475,000
Q4 2020

Feb 16, 2021

SELL
$5.21 - $6.42 $26,050 - $32,100
-5,000 Reduced 8.33%
55,000 $327,000
Q2 2020

Aug 13, 2020

SELL
$3.95 - $4.9 $39,500 - $49,000
-10,000 Reduced 14.29%
60,000 $284,000
Q1 2020

May 15, 2020

SELL
$3.79 - $5.92 $101,951 - $159,248
-26,900 Reduced 27.76%
70,000 $265,000
Q4 2019

Feb 05, 2020

SELL
$4.81 - $5.57 $111,110 - $128,667
-23,100 Reduced 19.25%
96,900 $499,000
Q3 2019

Nov 12, 2019

SELL
$5.15 - $6.55 $169,950 - $216,150
-33,000 Reduced 21.57%
120,000 $668,000
Q2 2019

Aug 13, 2019

BUY
$5.89 - $6.86 $135,470 - $157,780
23,000 Added 17.69%
153,000 $972,000
Q2 2019

Aug 13, 2019

SELL
$5.89 - $6.86 $135,470 - $157,780
-23,000 Reduced 15.03%
130,000 $845,000
Q1 2019

May 13, 2019

SELL
$5.91 - $8.09 $7,683 - $10,517
-1,300 Reduced 0.84%
153,000 $972,000
Q4 2017

Jan 25, 2018

BUY
$6.74 - $9.23 $138,170 - $189,215
20,500 Added 15.32%
154,300 $1.36 Million
Q3 2017

Nov 14, 2017

BUY
$5.44 - $7.7 $727,872 - $1.03 Million
133,800
133,800 $870,000

Others Institutions Holding ICCC

About IMMUCELL CORP


  • Ticker ICCC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,746,860
  • Market Cap $28.7M
  • Description
  • ImmuCell Corporation, an animal health company, develops, manufactures, and markets products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. It offers First Defense, an orally delivered scours preventive product for newborn dairy and beef calves; and Tri-Shield First Defense, a passive ...
More about ICCC
Track This Portfolio

Track Perritt Capital Management Inc Portfolio

Follow Perritt Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perritt Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Perritt Capital Management Inc with notifications on news.